EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management

Jose M Huguet iD, Luis Ferrer-Barceló iD, Patrícia Suárez iD, Susana Barcelo-Cerda iD, Javier Sempere iD, Ilaria Maria Saracino, Giulia Fiorini, Dino Vaira, Ángeles Pérez-Aísa, Laimas Jonaitis, Bojan Tepes iD, M Castro-Fernandez und 39 weitere

United European Gastroenterology Journal · 2024-07 · 12 (6) · 691-704

DOI: 10.1002/ueg2.12569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, online erschienen am 29.04.2024. Verfasst von Jose M Huguet und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hospital General Universitario de Valencia, Valencia, Spain. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Proton Pump Inhibitors, Registries. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UK Research and Innovation, HORIZON EUROPE European Innovation Council, European Union programme EU4Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adherence to Helicobacter pylori (H. pylori) eradication treatment is a cornerstone for achieving adequate treatment efficacy.

Objective

To determine which factors influence compliance with treatment.

Methods

A systematic prospective non‐interventional registry (Hp‐EuReg) of the clinical practice of European gastroenterologists. Compliance was considered adequate if ≥90% drug intake. Data were collected until September 2021 using the AEG‐REDCap e‐CRF and were subjected to quality control. Modified intention‐to‐treat analyses were performed. Multivariate analysis carried out the factors associated with the effectiveness of treatment and compliance.

Results

Compliance was inadequate in 646 (1.7%) of 38,698 patients. The non‐compliance rate was higher in patients prescribed longer regimens (10‐, 14‐days) and rescue treatments, patients with uninvestigated dyspepsia/functional dyspepsia, and patients reporting adverse effects. Prevalence of non‐adherence was lower for first‐line treatment than for rescue treatment (1.5% vs. 2.2%; p < 0.001). Differences in non‐adherence in the three most frequent first‐line treatments were shown: 1.1% with proton pump inhibitor + clarithromycin + amoxicillin; 2.3% with proton pump inhibitor clarithromycin amoxicillin metronidazole; and 1.8% with bismuth quadruple therapy. These treatments were significantly more effective in compliant than in non‐compliant patients: 86% versus 44%, 90% versus 71%, and 93% versus 64%, respectively ( p < 0.001). In the multivariate analysis, the variable most significantly associated with higher effectiveness was adequate compliance (odds ratio, 6.3 [95%CI, 5.2–7.7]; p < 0.001).

Conclusions

Compliance with Helicobacter pylori eradication treatment is very good. Factors associated with poor compliance include uninvestigated/functional dyspepsia, rescue‐treatment, prolonged treatment regimens, the presence of adverse events, and the use of non‐bismuth sequential and concomitant treatment. Adequate treatment compliance was the variable most closely associated with successful eradication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriProton Pump InhibitorsRegistriesAnti-Bacterial AgentsDrug Therapy, CombinationAmoxicillinDrug MonitoringHumansMaleFemaleMiddle AgedProspective StudiesEuropeAdultTreatment OutcomeClarithromycinAgedDyspepsiaMetronidazoleBismuth

Stichwörter der Autor:innen

adherenceadverse effectsbismuthdyspepsiaeffectivenessefficacyfirst linerateregimensrescue

Substanzen

Proton Pump InhibitorsAnti-Bacterial AgentsAmoxicillinClarithromycinMetronidazoleBismuth

Autor:innen und Institutionen

  • Department of Gastroenterology, Hospital General Universitario de Valencia, Valencia, Spain.
  • Department of Applied Statistics and Operational Research, and Quality, Universitat Politècnica de Valencia, Valencia, Spain.
  • IRCCS S. Orsola Polyclinic, University of Bologna, Bologna, Italy.
  • Agencia Sanitaria Costa del Sol, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Marbella, Spain.
  • Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Department of Gastroenterology, AM DC Rogaska, Rogaska Slatina, Slovenia.

ORCID-Profile: Jose M Huguet, Luis Ferrer-Barceló, Patrícia Suárez, Susana Barcelo-Cerda, Javier Sempere, Bojan Tepes, Manuel Pabón-Carrasco, Alfredo J Lucendo, Luis Rodrigo, Dmitry S Bordin, Doron Boltin, Jan Kral, Wojciech Marlicz, Marino Venerito, Olga P Nyssen, Javier P Gisbert

Förderung

  • UK Research and Innovation
  • HORIZON EUROPE European Innovation Council
  • European Union programme EU4Health
  • DIASORIN

Zitieren

APA

Huguet, J. M., Ferrer-Barceló, L., Suárez, P., Barcelo-Cerda, S., Sempere, J., Saracino, I. M., Fiorini, G., Vaira, D., Pérez-Aísa, Á., Jonaitis, L., Tepes, B., Castro-Fernandez, M., Pabón-Carrasco, M., Keco-Huerga, A., Voynovan, I., Lucendo, A. J., Lanas, Á., Martínez-Domínguez, S. J., Alfaro Almajano, E., …, & Hp‐EuReg Investigators (2024). Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management. United European Gastroenterology Journal, 12(6), 691-704. https://doi.org/10.1002/ueg2.12569

Vancouver

Huguet JM, Ferrer-Barceló L, Suárez P, Barcelo-Cerda S, Sempere J, Saracino IM, et al. Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management. United European Gastroenterology Journal. 2024;12(6):691-704. doi:10.1002/ueg2.12569

BibTeX
@article{Huguet2024,
  author = {Huguet, Jose M and Ferrer-Barceló, Luis and Suárez, Patrícia and Barcelo-Cerda, Susana and Sempere, Javier and Saracino, Ilaria Maria and Fiorini, Giulia and Vaira, Dino and Pérez-Aísa, Ángeles and Jonaitis, Laimas and Tepes, Bojan and Castro-Fernandez, M and Pabón-Carrasco, Manuel and Keco-Huerga, Alma and Voynovan, Irina and Lucendo, Alfredo J and Lanas, Ángel and Martínez-Domínguez, Samuel J and Alfaro Almajano, Enrique and Rodrigo, Luis and Vologzanina, Ludmila and Bordin, Dmitry S and Gasbarrini, Antonio and Babayeva, Gülüstan and Lerang, Frode and Leja, Mārcis and Kupčinskas, Juozas and Rokkas, Theodore and Marcos-Pinto, Ricardo and Meštrović, Antonio and Gridnyev, Oleksiy and Phull, Perminder S and Smith, Sinead M and Boltin, Doron and Buzás, György Miklós and Kral, Jan and Şimşek, Halis and Matysiak-Budnik, Tamara and Milivojevic, Vladimir and Marlicz, Wojciech and Venerito, Marino and Boyanova, Lyudmila and Doulberis, Michael and Capelle, Lisette G and Cano-Català, Anna and Moreira, Leticia and Nyssen, Olga P and Mégraud, Francis and O'Morain, Colm and Gisbert, Javier P and Hp‐EuReg Investigators, Hp‐EuReg Investigators},
  title = {Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  volume = {12},
  number = {6},
  pages = {691--704},
  doi = {10.1002/ueg2.12569}
}
Kostenlos starten →